NCCM
FOLD

Nine Chapters Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Nine Chapters Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-33,300
Closed -$198K – 1020
2014
Q3 		$198K Buy
+33,300
New +$174K 0.02% 856

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nine Chapters Capital Management's FOLD Position: Q4 2014 in Review

Nine Chapters Capital Management sold out of Amicus Therapeutics (FOLD) in Q4 2014, closing a stake of 33,300 shares — an estimated $198K sold.

Nine Chapters Capital Management first reported a position in FOLD in Q3 2014 and held it in 1 quarter. The position peaked at $198K in Q3 2014. 109 funds tracked by Wall St. Rank hold FOLD as of Q4 2014.

  • Nine Chapters Capital Management reported no remaining Amicus Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Nine Chapters Capital Management sold 33,300 Amicus Therapeutics shares in Q4 2014, an estimated $198K.
  • Nine Chapters Capital Management first reported a position in Amicus Therapeutics in Q3 2014 and held it in 1 quarter.
  • Nine Chapters Capital Management's Amicus Therapeutics position peaked at $198K in Q3 2014.
  • 109 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2014.

Based on Nine Chapters Capital Management's 13F filing for Q4 2014, filed 9 Feb 2015.